GJB2 rs76173978: Understanding Your Hearing Carrier Status
The genetic variant rs76173978 is a rare single-nucleotide change located in the GJB2 gene on chromosome 13. Research links this variant to autosomal recessive nonsyndromic hearing loss when inherited alongside another pathogenic alteration in the same gene. Individuals carrying only a single copy of this variant are asymptomatic carriers who typically retain normal hearing.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| Reference / Reference (Homozygous Wild-Type) | You carry two common, reference copies of the GJB2 gene at position rs76173978. You are not a carrier for this specific variant and have no elevated personal or reproductive risk associated with it. Standard general-population risks for hereditary hearing loss still apply. | Favorable |
| Reference / Variant (Heterozygous Carrier) | You carry one reference allele and one altered allele at position rs76173978. You are an asymptomatic carrier who is expected to have normal hearing. A reproductive partner would also need to carry a pathogenic GJB2 variant for a child to have an elevated risk of recessive hearing loss. | Informational |
| Variant / Variant (Homozygous Variant) | You carry two copies of the rs76173978 variant in the GJB2 gene. In the medical literature, biallelic alterations in GJB2 are associated with nonsyndromic sensorineural hearing loss. Formal clinical audiologic and genetic evaluations are recommended to evaluate inner ear function. | Higher attention |
Genetic Architecture and Location
The single-nucleotide variant rs76173978 resides within the GJB2 gene, situated on chromosome 13 at the cytogenetic locus 13q12.11. The GJB2 gene contains instructions for assembling gap junction beta-2, a structural protein frequently referred to as connexin 26. In the inner ear, connexin 26 subunits join with neighboring subunits to assemble intercellular gap junctions, forming microscopic channels that permit the passage of ions and small signaling molecules directly between adjacent cells. The rs76173978 alteration affects the coding sequence of this protein, creating a missense change where a single amino acid is replaced. Because connexin 26 depends on a precise conformation to form functioning hexameric channels, amino acid changes can disrupt channel assembly, conductance, or stability within the delicate cellular networks of the cochlea.
Connexin 26 Function and Hearing Biology
Hearing relies on the rapid movement of potassium ions (K+) through sensory hair cells in the cochlea during sound stimulation. When sound waves vibrate the structures within the cochlea, hair cells depolarize as potassium enters from the potassium-rich endolymph. To maintain hearing sensitivity and avoid toxic cellular buildup, this potassium must be continuously recycled back to the stria vascularis through the gap junction network formed predominantly by connexin 26. When pathogenic variants impair connexin 26 function, this essential recycling pathway is compromised. The resulting ionic imbalance damages cochlear tissues, leading to sensorineural hearing impairment. The GJB2 gene is the most widely documented contributor to hereditary nonsyndromic hearing loss worldwide, accounting for up to 50% of autosomal recessive nonsyndromic deafness cases across diverse human populations.
Clinical Significance and Strength of Evidence
Evidence evaluating rs76173978 indicates that it acts in an autosomal recessive inheritance pattern. Autosomal recessive nonsyndromic hearing loss (AR-NSHL) requires loss-of-function or damaging alterations on both copies of the GJB2 gene—either as a homozygote (two copies of rs76173978) or as a compound heterozygote (one copy of rs76173978 paired with a different pathogenic GJB2 variant, such as c.35delG or c.235delC). The overall clinical evidence specific to rs76173978 is categorized as limited relative to common founder mutations, due to its low occurrence in clinical registries and population cohorts. Individuals carrying only one variant copy have enough functional connexin 26 to maintain potassium recycling and do not experience hearing deficits solely from their carrier status.
Population Prevalence and Allele Frequencies
Data from large-scale reference databases, such as the Genome Aggregation Database (gnomAD), indicate that the alternative allele of rs76173978 is exceedingly rare globally, with an estimated allele frequency of approximately 0.0001 (0.01%). This means roughly one in every 5,000 to 10,000 sequenced chromosomes carries this specific variant. Unlike major founder mutations in GJB2—such as c.35delG in individuals of European ancestry, c.167delT in Ashkenazi Jewish populations, or c.235delC in East Asian populations—rs76173978 does not demonstrate widespread geographic or ancestral enrichment. Because pathogenic GJB2 variants overall are common among congenital hearing loss etiologies, carrier screening panels sometimes include rarer alleles like rs76173978 to provide broader diagnostic sensitivity across diverse backgrounds.
Practical Implications and Genetic Counseling
Discovering an rs76173978 variant on a consumer genetic report or clinical carrier screen does not mean you have or will develop hearing loss. Because it is inherited in a recessive fashion, a single copy merely indicates carrier status. A carrier could potentially pass the variant to offspring with a 50% probability per pregnancy. A child is only at risk of GJB2-related hearing loss if the other biological parent also carries a pathogenic GJB2 variant, in which case there is a 25% chance of the child inheriting both altered copies. If you or your reproductive partner test positive as a carrier, consulting a certified genetic counselor or medical geneticist can help clarify reproductive risks, guide formal carrier screening, and explain the nuance of compound heterozygosity.
How common is this variant?
The rs76173978 variant is very rare worldwide, exhibiting a global minor allele frequency of approximately 0.0001 (~0.01%) in the gnomAD database, with no marked enrichment documented in specific ancestral populations.
Frequently asked questions
Does having the rs76173978 variant mean I will go deaf?
No, carrying a single copy of rs76173978 means you are an asymptomatic carrier and will typically have normal hearing. Recessive hearing loss requires inheriting two nonfunctional GJB2 variants, one from each parent. A single variant copy does not cause progressive hearing loss on its own.
What is the difference between syndromic and nonsyndromic hearing loss?
Nonsyndromic hearing loss refers to hearing impairment that occurs in isolation, without any other medical features, skin changes, or organ complications. In contrast, syndromic hearing loss occurs as part of a broader condition that involves other body systems, such as the eyes, heart, or kidneys.
What should I do if my reproductive partner and I are both carriers?
If both biological parents carry a pathogenic variant in the GJB2 gene, there is a 25% chance with each pregnancy that a child will inherit both variants and experience sensorineural hearing loss. Speaking with a certified genetic counselor can provide detailed information about reproductive options and prenatal or newborn hearing assessments.
Is GJB2-related hearing loss treatable?
While the underlying genetic change cannot be reversed, individuals with GJB2-related sensorineural hearing loss respond exceptionally well to standard auditory interventions. Because the auditory nerve and inner ear architecture remain largely intact, hearing aids and cochlear implants typically provide significant benefits.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs76173978?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29